Skip to main content
NVDA+0.85%AAPL+0.97%MSFT+0.23%GOOGL+1.12%AMZN+1.15%TSM+2.77%SPCX+1.90%AVGO+3.61%META-0.93%TSLA+3.50%LLY+0.82%BRK-B-0.59%MU+2.48%SKHY+2.07%WMT-0.86%AMD+4.93%JPM+0.64%V-0.68%XOM-1.63%JNJ+0.78%ASMLa+2.49%MA-0.39%ABBV+0.04%INTC+3.08%1398.HK+2.15%CVX-1.44%0700.HK-0.31%COST-0.93%CSCO+1.78%KO-0.46%ORCL+3.27%UNH+0.32%PG-0.62%BAC+0.43%1816.HK+1.32%3988.HK+0.66%CAT+2.61%DELL+7.69%HD+0.07%PM+0.68%0857.HK-0.98%0939.HK+0.81%AMAT+1.54%AP2d+1.36%GE+2.51%1288.HK+0.60%LRCX+0.50%0005.HK-5.56%NVS+1.14%MS+1.44%USDJPY+0.63%AUDJPY+0.62%NZDMXN+0.55%NZDJPY+0.55%AUDDKK+0.53%EURUSD-0.53%EURAUD-0.52%EURZAR-0.52%EURSEK-0.47%AUDCHF+0.47%EURNZD-0.47%USDCHF+0.46%GBPZAR-0.44%GBPUSD-0.44%GBPAUD-0.43%CADJPY+0.42%GBPTRY+0.41%NZDCHF+0.39%GBPNZD-0.36%AUDNOK+0.35%CHFSEK-0.33%EURCNH-0.33%GBPHKD+0.32%USDMXN+0.30%EURCAD-0.29%EURHKD-0.29%GBPMXN-0.28%EURSGD-0.28%USDDKK+0.28%NZDSGD+0.25%AUDSGD+0.25%CADCHF+0.25%GBPCAD-0.23%USDZAR-0.23%SGDJPY+0.23%USDCAD+0.22%GBPSGD-0.21%AUDCAD+0.21%USDSEK-0.20%EURNOK-0.18%GBPJPY+0.18%USDTRY+0.18%CHFJPY+0.17%USDILS+0.16%USDPLN+0.15%CHFSGD-0.14%NZDCAD+0.14%NOKJPY+0.13%EURPLN-0.12%EURJPY+0.11%USDNOK+0.10%EURGBP-0.08%USDTHB-0.08%NZDUSD-0.08%EURCHF-0.08%PLNJPY+0.08%AUDNZD+0.06%EURCZK-0.06%USDCNH-0.04%USDCOP-0.04%CHFNOK-0.04%USDHKD+0.04%GBPCHF+0.01%USDSGD-0.01%AUDUSD-0.01%EURDKK0.00%COFFEE-2.53%HG1+1.55%COTTON-1.15%USOIL-1.09%GAUUSD+1.02%XAUUSD+1.02%UKOIL-0.91%XAGUSD+0.88%GAGUSD+0.88%S1-0.75%XNGUSD-0.63%XPTUSD+0.55%BTCUSD+0.58%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.18%ZECUSDT+4.89%DOGEUSD+20.65%XMRUSDT-1.15%LINKUSD+25.58%BCHUSDT+2.90%XLMUSD+0.02%UNIUSD-0.52%LTCUSD+17.89%SUIUSD+0.71%HBARUSDT-1.70%TONUSD+41.71%TAOUSDT-0.10%AAVEUSD-2.86%DOTUSDT-1.78%ICPUSDT-1.56%ONDOUSDT+0.32%WLDUSDT+0.14%ARBUSDT-0.16%JUPUSDT+0.66%INJUSDT+0.99%ATOMUSDT-0.88%STXUSDT-1.08%TIAUSDT-1.98%PYTHUSDT-2.94%FETUSDT+3.47%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.63%OPUSDT-0.20%IOTAUSDT+1.14%WIFUSDT-0.61%POLUSDT-0.25%AXSUSDT+0.51%EOSUSDT+0.92%FARTCOINUSDT+1.90%DYDXUSDT+1.80%GALAUSDT-0.17%ORDIUSDT+1.33%RONINUSDT+1.89%NOTUSDT+1.92%NVDA+0.85%AAPL+0.97%MSFT+0.23%GOOGL+1.12%AMZN+1.15%TSM+2.77%SPCX+1.90%AVGO+3.61%META-0.93%TSLA+3.50%LLY+0.82%BRK-B-0.59%MU+2.48%SKHY+2.07%WMT-0.86%AMD+4.93%JPM+0.64%V-0.68%XOM-1.63%JNJ+0.78%ASMLa+2.49%MA-0.39%ABBV+0.04%INTC+3.08%1398.HK+2.15%CVX-1.44%0700.HK-0.31%COST-0.93%CSCO+1.78%KO-0.46%ORCL+3.27%UNH+0.32%PG-0.62%BAC+0.43%1816.HK+1.32%3988.HK+0.66%CAT+2.61%DELL+7.69%HD+0.07%PM+0.68%0857.HK-0.98%0939.HK+0.81%AMAT+1.54%AP2d+1.36%GE+2.51%1288.HK+0.60%LRCX+0.50%0005.HK-5.56%NVS+1.14%MS+1.44%USDJPY+0.63%AUDJPY+0.62%NZDMXN+0.55%NZDJPY+0.55%AUDDKK+0.53%EURUSD-0.53%EURAUD-0.52%EURZAR-0.52%EURSEK-0.47%AUDCHF+0.47%EURNZD-0.47%USDCHF+0.46%GBPZAR-0.44%GBPUSD-0.44%GBPAUD-0.43%CADJPY+0.42%GBPTRY+0.41%NZDCHF+0.39%GBPNZD-0.36%AUDNOK+0.35%CHFSEK-0.33%EURCNH-0.33%GBPHKD+0.32%USDMXN+0.30%EURCAD-0.29%EURHKD-0.29%GBPMXN-0.28%EURSGD-0.28%USDDKK+0.28%NZDSGD+0.25%AUDSGD+0.25%CADCHF+0.25%GBPCAD-0.23%USDZAR-0.23%SGDJPY+0.23%USDCAD+0.22%GBPSGD-0.21%AUDCAD+0.21%USDSEK-0.20%EURNOK-0.18%GBPJPY+0.18%USDTRY+0.18%CHFJPY+0.17%USDILS+0.16%USDPLN+0.15%CHFSGD-0.14%NZDCAD+0.14%NOKJPY+0.13%EURPLN-0.12%EURJPY+0.11%USDNOK+0.10%EURGBP-0.08%USDTHB-0.08%NZDUSD-0.08%EURCHF-0.08%PLNJPY+0.08%AUDNZD+0.06%EURCZK-0.06%USDCNH-0.04%USDCOP-0.04%CHFNOK-0.04%USDHKD+0.04%GBPCHF+0.01%USDSGD-0.01%AUDUSD-0.01%EURDKK0.00%COFFEE-2.53%HG1+1.55%COTTON-1.15%USOIL-1.09%GAUUSD+1.02%XAUUSD+1.02%UKOIL-0.91%XAGUSD+0.88%GAGUSD+0.88%S1-0.75%XNGUSD-0.63%XPTUSD+0.55%BTCUSD+0.58%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.18%ZECUSDT+4.89%DOGEUSD+20.65%XMRUSDT-1.15%LINKUSD+25.58%BCHUSDT+2.90%XLMUSD+0.02%UNIUSD-0.52%LTCUSD+17.89%SUIUSD+0.71%HBARUSDT-1.70%TONUSD+41.71%TAOUSDT-0.10%AAVEUSD-2.86%DOTUSDT-1.78%ICPUSDT-1.56%ONDOUSDT+0.32%WLDUSDT+0.14%ARBUSDT-0.16%JUPUSDT+0.66%INJUSDT+0.99%ATOMUSDT-0.88%STXUSDT-1.08%TIAUSDT-1.98%PYTHUSDT-2.94%FETUSDT+3.47%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.63%OPUSDT-0.20%IOTAUSDT+1.14%WIFUSDT-0.61%POLUSDT-0.25%AXSUSDT+0.51%EOSUSDT+0.92%FARTCOINUSDT+1.90%DYDXUSDT+1.80%GALAUSDT-0.17%ORDIUSDT+1.33%RONINUSDT+1.89%NOTUSDT+1.92%
AS

AstraZeneca PLC (AZN)

NYSE • Healthcare

$171.35
-$0.71 (-0.4%)
Market open

October 27, 2026 at 15:46 UTC

Open$171.54
Previous Close$172.06
Day Range$170.68 - $172.37
Avg. Volume (3M)2.9M
Market Cap$266B
P/E Ratio25.6
52 Week Range
$153.41$212.71
Next EarningsIn 3 daysOct 30, 2026

Interactive Chart

15:46:59 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$15.3B100%
Gross Profitminus cost of goods$12.8B84%
Operating Incomeminus R&D and overhead$3.1B21%
Net Incomeminus taxes and the rest$2.5B16%

In plain terms: out of every $100 in revenue, AstraZeneca PLC keeps $16 as net profit.

Fundamentals & Financials

Revenue (TTM)
$61.3B
Net Income (TTM)
$10.4B
EPS (TTM)
$6.72
ROA (TTM)
8.96%
Current Ratio
0.89
Dividend Yield
0.0022%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.4%Q1 2026$2.12
+0.4%Q2 2026$2.58
+5.2%Q3 2026$2.63
Next

Oct 30

in 3 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +5.2%

AstraZeneca's adjusted EPS topped consensus while revenue came in just below estimates in the second fiscal quarter of 2026, reported July 27. Revenue rose about 5% to about $15.2 billion from about $14.5 billion a year ago, but it missed the about $15.4 billion consensus by 0.3%, while adjusted EPS of $2.63 topped the $2.50 estimate by 5.2% and was up from $2.18 a year ago. Net income rose about 1% to about $2.5 billion, with gross margin near 74% and operating margin around 20% as operating income reached about $3.1 billion. The company generated operating cash flow of about $2.9 billion and paid $6.3 million in dividends. Consensus for the next period calls for EPS of $2.63 on revenue of $16.07 billion.

Next report — what to expect

AstraZeneca PLC (AZN) is set to report earnings on October 30, 2026. Wall Street consensus calls for EPS of $2.62 on revenue of $16.06 billion. For trailing context, revenue grew +6.4% year over year last quarter. AstraZeneca has beaten EPS in 7 of 8 most recent quarters.

View full earnings history

About AstraZeneca PLC

AstraZeneca PLC develops and sells prescription medicines as a large pharmaceutical company listed on the NYSE under AZN, spanning discovery, development, manufacturing, and commercialization. Its portfolio generated $58.7 billion in FY2025 revenue across treatments for cancer, cardiovascular, renal and metabolic conditions, COVID-19, and rare diseases.

Name
AstraZeneca PLC
CEO
Pascal Claude Roland Soriot
Website
www.astrazeneca.com
Industry
Healthcare
Year Founded
1992
Employees
96,100

Today's Snapshot

AI-generated

AZN opened 1.4% below yesterday's close, while its sector was flat. AstraZeneca reported positive Phase III results for a cancer drug. Earnings are due from AZN on 30 October.

Trading Volume

Below 10d avg (3.0M)

539.5K

vs S&P 500 Today

Underperforming Market

-0.82%

Updated: October 27, 2026 at 14:37 UTC

AZN Headlines

AstraZeneca debuts ZEGFROVY in US lung cancer

October 22, 2026

4 min read

FDA clears Ultomiris for IgAN proteinuria

October 22, 2026

3 min read

AstraZeneca breast cancer trial setback

September 11, 2026

3 min read

FDA clears AstraZeneca breast cancer drug

September 4, 2026

2 min read
View All News

Technical Indicators

5 Buy1 Neutral2 Sell
AZN presents a modest buy stance led by short- and medium-term strength and positive momentum, even as longer-term levels act as resistance. The MACD and shorter moving averages are supporting higher prices and the RSI shows constructive momentum, while the ADX remains subdued, indicating a lack of strong trend conviction. Volatility is muted and on-balance volume shows signs of buying pressure despite an overall negative level, and the stock sits below the 200-day average, which is a longer-term caution. Technical takeaway: Modest buy bias supported by short-term momentum but capped by the higher 200-day level.
All signals
  • EMA (5 indicators)$165.24 - $175.77
    Buy
  • RSI (14)60.04
    Neutral
  • Stochastic %K (14, 3, 3)87.28
    Sell
  • MACD Level (12, 26)2.34
    Buy

Peers & Related Assets

LLYEli Lilly and Company
$1287.24+0.6%
JNJJohnson & Johnson
$267.71+0.5%
ABBVAbbVie Inc.
$286.39-0.1%
MRKMerck & Co., Inc.
$140.61-3.2%
NVSNovartis AG
$155.39+1.0%
AMGNAmgen Inc.
$446.6+0.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.